Ureaplasma urealyticum: Diagnosis and Treatment
For urethritis caused by Ureaplasma urealyticum, treat with doxycycline 100 mg twice daily orally for 7 days, with azithromycin 1 g single dose as an alternative. 1
Diagnostic Approach
For Urethritis
- Perform validated NAAT (nucleic acid amplification test) on first-void urine or urethral smear prior to empirical treatment 1
- If symptoms are mild, delay treatment until NAAT results are available to guide therapy 1
- In severe urethritis, commence empirical treatment immediately upon diagnosis 1
Important caveat: The pathogenic role of Ureaplasma species in urethritis is debated. Recent evidence suggests that U. urealyticum (but not U. parvum) is an aetiological agent in nongonococcal urethritis 1. This distinction matters—not all Ureaplasma species require treatment.
For Pregnant Patients
Do not perform routine Ureaplasma/Mycoplasma cervical culture screening in pregnant patients, even those at high risk for preterm birth 2. The evidence shows:
- Treatment failure rate after antibiotics is 78.6% 2
- No decreased risk of preterm birth with treatment (HR: 0.91; 95% CI: 0.66-1.27) 2
- Insufficient evidence that antibiotics prevent preterm birth in colonized women 3
Treatment Regimens
First-Line Treatment for U. urealyticum Urethritis
Doxycycline 100 mg orally twice daily for 7 days 1
Alternative Regimen
Azithromycin 1 g orally as a single dose 1
Partner Management
All sexual partners at risk should be assessed and treated while maintaining patient confidentiality 1
Clinical Context and Pitfalls
Common Diagnostic Pitfalls
- Routine microbiology has limited sensitivity: Ureaplasma requires specialized culture or molecular detection 4
- Gram staining is uninformative due to lack of cell wall 4
- Culture sensitivity is below 10% compared with PCR testing 5
Antibiotic Resistance Considerations
- Intrinsic resistance to beta-lactams and glycopeptides due to lack of cell wall 4
- Macrolide- and fluoroquinolone-resistant isolates have been observed in clinical practice 6
- Regional resistance patterns vary significantly: North American/German isolates show <8% resistance to key agents, while Vietnamese surveillance found 76% ciprofloxacin resistance in U. urealyticum 4
When NOT to Treat
- Asymptomatic colonization in pregnancy: No benefit demonstrated 3, 2
- U. parvum detection: Not considered pathogenic in urethritis 1
- Positive culture without symptoms: High colonization rates exist in healthy reproductive-age women 6
Neonatal Considerations
For preterm infants with suspected Ureaplasma infection, the organism is associated with serious complications including bronchopulmonary dysplasia (pooled OR 2.30,95% CI 1.65-3.20), intraventricular hemorrhage (pooled OR 1.62,95% CI 1.23-2.13), and neurodevelopmental impairment 5. However, no randomized trial has shown that microbiological eradication translates into better clinical outcomes 5.